Bacterial invasion of vascular cell types: Vascular infectology and atherogenesis

Future Cardiology

Volumn 8, Issue 1, 2012, Pages 123-138

  Kozarov, Emil ^a  

^a Department of Medicine   (United States)

Author keywords

atherosclerosis; bacterial invasion; chronic inflammation; etiology; infection

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL DNA; C REACTIVE PROTEIN; CLARITHROMYCIN; DNA 16S; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN G; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; METRONIDAZOLE; PADGEM PROTEIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ACUTE HEART INFARCTION; AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ANAEROBIC INFECTION; ANGIOCARDIOGRAPHY; ANTIBIOTIC THERAPY; APOPTOSIS; ATHEROGENESIS; ATHEROMA; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; AUTOLYSOSOME; AUTOPHAGOSOME; B LYMPHOCYTE; BACTEREMIA; BACTERIAL INFECTION; BACTERIAL LOAD; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; BIOFILM; BLOOD CLOTTING; CARDIOVASCULAR INFECTION; CARDIOVASCULAR RISK; CELL CONTACT; CHLAMYDIAL PNEUMONIA; CHLAMYDOPHILA PNEUMONIAE; DIABETES MELLITUS; DNA FINGERPRINTING; EDENTULOUSNESS; EIKENELLA CORRODENS; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INTERNALIZATION; ISCHEMIC HEART DISEASE; LIPID RAFT; MACROPHAGE; META ANALYSIS (TOPIC); METAGENOMICS; MICROBIOME; MOUTH DISEASE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PASTEURELLACEAE INFECTION; PERIODONTAL DISEASE; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PREVOTELLA INTERMEDIA; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; PROSTHETIC VALVE ENDOCARDITIS; PROTEIN BLOOD LEVEL; PYROSEQUENCING; REVIEW; SALMONELLA INFANTIS; SEROEPIDEMIOLOGY; SIGNAL TRANSDUCTION; SMOKING; SMOOTH MUSCLE FIBER; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS MUTANS; T LYMPHOCYTE; TANNERELLA FORSYTHENSIS; THROMBOSIS; TREPONEMA DENTICOLA; UNSTABLE ANGINA PECTORIS; VASCULAR TISSUE;

ARTERIOSCLEROSIS; BACTERIAL INFECTIONS; CARDIOVASCULAR SYSTEM; CHRONIC DISEASE; DENDRITIC CELLS; ENDOTHELIUM, VASCULAR; HUMANS; HYPERTENSION; INFLAMMATION; MYOCARDIAL INFARCTION; PERIODONTAL DISEASES; UNITED STATES;

EID: 84555190776     PISSN: 14796678     EISSN: 17448298     Source Type: Journal    
DOI: 10.2217/fca.11.75     Document Type: Review

References (133)

1. Katz JT, Shannon RP. Bacteria and coronary atheroma: more fngerprints but no smoking gun. Circulation 113(7), 920-922 (2006). (Pubitemid 43879464)
2. Van Dyke TE, Kornman KS. Infammation and factors that may regulate infammatory response. J. Periodontol. 79(Suppl. 8), 1503-1507 (2008).
3. Libby P, Ridker PM, Hansson GK. Infammation in atherosclerosis: from pathophysiology to practice. J. Am. Coll. Cardiol. 54(23), 2129-2138 (2009).
4. Libby P, Okamoto Y, Rocha VZ, Folco E. Infammation in atherosclerosis: transition from theory to practice. Circ. J. 74(2), 213-220 (2010).
5. Gilbert A, Lion, G. Arterites infectieuses experimentales. CR Hebd Sciences Mem. Soc. Biol. 41, 583-584 (1889).
6. Fabricant CG, Fabricant J, Litrenta MM, Minick CR. Virus-induced atherosclerosis. J. Exp. Med. 148(1), 335-340 (1978). (Pubitemid 8376500)
7. Ross R. Atherosclerosis-an infammatory disease. N. Engl. J. Med. 340(2), 115-126 (1999).
8. Grau AJ, Marquardt L, Lichy C. The effect of infections and vaccinations on stroke risk. Expert Rev. Neurother. 6(2), 175-183 (2006).
9. Epstein SE, Zhu J, Najaf AH, Burnett MS. Insights into the role of infection in atherogenesis and in plaque rupture. Circulation 119(24), 3133-3141 (2009).
10. Libby P, Ridker PM, Maseri A. Infammation and atherosclerosis. Circulation 105(9), 1135-1143 (2002).
11. Ridker PM. On evolutionary biology, infammation, infection, and the causes of atherosclerosis. Circulation 105(1), 2-4 (2002). (Pubitemid 34049132)
12. Saikku P, Leinonen M, Mattila K et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 2(8618), 983-986 (1988).
13. Espinola-Klein C, Rupprecht HJ, Blankenberg S et al. Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation 105(1), 15-21 (2002). (Pubitemid 34049136)
14. Frostegard J. Low level natural antibodies against phosphorylcholine: a novel risk marker and potential mechanism in atherosclerosis and cardiovascular disease. Clin. Immunol. 134(1), 47-54 (2010).
15. Elkind MS. Infectious burden: a new risk factor and treatment target for atherosclerosis. Infect. Disord. Drug Targets 10(2), 84-90 (2010).
16. Tonetti MS. Periodontitis and risk for atherosclerosis: an update on intervention trials. J. Clin. Periodontol. 36(Suppl. 10), 15-19 (2009).
17. Kebschull M, Demmer RT, Papapanou PN. "Gum bug, leave my heart alone!"-epidemiologic and mechanistic evidence linking periodontal infections and atherosclerosis. J. Dent. Res. 89(9), 879-902 (2010).
18. Demmer RT, Desvarieux M. Periodontal infections and cardiovascular disease: the heart of the matter. J. Am. Dent. Assoc. 137(Suppl.) 14S-20S; quiz 38S (2006). (Pubitemid 44643017)
19. Zoellner H. Dental infection and vascular disease. Semin. Thromb. Hemost. 37(3), 181-192 (2011).
20. Desvarieux M, Demmer RT, Rundek T et al. Periodontal microbiota and carotid intima-media thickness: the oral infections and vascular disease epidemiology study (INVEST). Circulation 111(5), 576-582 (2005). (Pubitemid 40216484)
21. Renvert S, Pettersson T, Ohlsson O, Persson GR. Bacterial profle and burden of periodontal infection in subjects with a diagnosis of acute coronary syndrome. J. Periodontol. 77(7), 1110-1119 (2006). (Pubitemid 44725016)
22. Engebretson SP, Lamster IB, Elkind MS et al. Radiographic measures of chronic periodontitis and carotid artery plaque. Stroke 36(3), 561-566 (2005). (Pubitemid 40344157)
23. Nonnenmacher C, Stelzel M, Susin C et al. Periodontal microbiota in patients with coronary artery disease measured by real-time polymerase chain reaction: a case-control study. J. Periodontol. 78(9), 1724-1730 (2007).
24. Volzke H, Schwahn C, Hummel A et al. Tooth loss is independently associated with the risk of acquired aortic valve sclerosis. Am. Heart J. 150(6), 1198-1203 (2005). (Pubitemid 41773522)
25. Mattila KJ, Pussinen PJ, Paju S. Dental infections and cardiovascular diseases: a review. J. Periodontol. 76(Suppl. 11), 2085-2088 (2005). (Pubitemid 41748957)
26. Yamazaki K, Honda T, Domon H et al. Relationship of periodontal infection to serum antibody levels to periodontopathic bacteria and infammatory markers in periodontitis patients with coronary heart disease. Clin. Exp. Immunol. 149(3), 445-452 (2007). (Pubitemid 47256164)
27. Pesonen E, El-Segaier M, Persson K et al. Infections as a stimulus for coronary occlusion, obstruction, or acute coronary syndromes. Ther. Adv. Cardiovasc. Dis. 3(6), 447-454 (2009).
28. Colhoun HM, Slaney JM, Rubens MB, Fuller JH, Sheiham A, Curtis MA. Antibodies to periodontal pathogens and coronary artery calcifcation in Type 1 diabetic and nondiabetic subjects. J. Periodontal Res. 43(1), 103-110 (2008).
29. Tew JG, El Shikh ME, El Sayed RM, Schenkein HA. Dendritic cells, antibodies reactive with oxLDL, and infammation. J. Dent. Res. doi:10. 1177/0022034511407338 (2011) (Epub ahead of print).
30. Mustapha IZ, Debrey S, Oladubu M, Ugarte R. Markers of systemic bacterial exposure in periodontal disease and cardiovascular disease risk: a systematic review and meta-analysis. J. Periodontol. 78(12), 2289-2302 (2007).
31. Jimenez M, Krall EA, Garcia RI, Vokonas PS, Dietrich T Periodontitis and incidence of cerebrovascular disease in men. Ann. Neurol. 66(4), 505-512 (2009).
32. Hayashi C, Gudino CV, Gibson FC 3rd, Genco CA. Review: pathogen-induced infammation at sites distant from oral infection: bacterial persistence and induction of cell-specifc innate immune infammatory pathways. Mol. Oral Microbiol. 25(5), 305-316 (2010).
33. Teles R, Wang CY. Mechanisms involved in the association between peridontal diseases and cardiovascular disease. Oral Dis. 17(5), 450-461 (2011).
34. Iwai T Periodontal bacteremia and various vascular diseases. J. Periodontal Res. 44(6), 689-694 (2009).
35. Kinane DF, Riggio MP, Walker KF, MacKenzie D, Shearer B. Bacteraemia following periodontal procedures. J. Clin. Periodontol. 32(7), 708-713 (2005). (Pubitemid 40923043)
36. Lockhart PB, Brennan MT, Thornhill M et al. Poor oral hygiene as a risk factor for infective endocarditis-related bacteremia. J. Am. Dent. Assoc. 140(10), 1238-1244 (2009).
37. Libby P. Infammatory mechanisms: the molecular basis of infammation and disease. Nutr. Rev. 65(12 Pt 2), S140-S146 (2007).
38. Andrew P, Montenero AS. Is there a link between atrial fbrillation and certain bacterial infections? J. Cardiovasc. Med. (Hagerstown), 8(12), 990-996 (2007). (Pubitemid 351339555)
39. Campbell LA, Kuo CC. Chlamydia pneumoniae-an infectious risk factor for atherosclerosis? Nat. Rev. Microbiol. 2(1), 23-32 (2004). (Pubitemid 39490045)
40. Vainas T, Stassen FR, Schurink GW et al. Secondary prevention of atherosclerosis through Chlamydia pneumoniae eradication (SPACE Trial): a randomized clinical trial in patients with peripheral arterial disease. Eur. J. Vasc. Endovasc. Surg. 29(4), 403-411 (2005). (Pubitemid 40331377)
41. Nicolle L. Chlamydia pneumoniae and atherosclerosis: the end? Can. J. Infect. Dis. Med. Microbiol. 16(5), 267-268 (2005). (Pubitemid 41719716)
42. Joensen JB, Juul S, Henneberg E, Thomsen G, Ostergaard L, Lindholt JS. Can long-term antibiotic treatment prevent progression of peripheral arterial occlusive disease? A large, randomized, double-blinded, placebo-controlled trial. Atherosclerosis 196(2), 937-942 (2008).
43. Harskamp RE, van Ginkel MW. Acute respiratory tract infections: a potential trigger for the acute coronary syndrome. Ann. Med. 40(2), 121-128 (2008). (Pubitemid 351640648)
44. Elkind MSV, Ramakrishnan P, Moon YP et al. Infectious burden and risk of stroke: the northern Manhattan study. Arch. Neurol. 67(1), 33-38 (2010).
45. Elkind MS, Luna JM, Moon YP et al. Infectious burden and carotid plaque thickness: the northern Manhattan study. Stroke 41(3), e1 17-e122 (2010).
46. Monack DM, Mueller A, Falkow S. Persistent bacterial infections: the interface of the pathogen and the host immune system. Nat. Rev. Microbiol. 2(9), 747-765 (2004). (Pubitemid 39200066)
47. Tufariello JM, Chan J, Flynn JL. Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection. Lancet Infect. Dis. 3(9), 578-590 (2003). (Pubitemid 37064537)
48. Kozarov E, Sweier D, Shelburne C, Progulske-Fox A, Lopatin D. Detection of bacterial DNA in atheromatous plaques by quantitative PCR Microbes Infect. 8(3), 687-693 (2006).
49. Ott SJ, El Mokhtari NE, Musfeldt M et al. Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease. Circulation 113(7), 929-937 (2006). (Pubitemid 43879467)
50. Lewis K. Persister cells, dormancy and infectious disease. Nat. Rev. Microbiol. 5(1), 48-56 (2007). (Pubitemid 44942303)
51. Lidar M, Lipschitz N, Langevitz P, Shoenfeld Y. The infectious etiology of vasculitis. Autoimmunity 42(5), 432-438 (2009).
52. Zeituni AE, Carrion J, Cutler CW. Porphyromonas gingivalis-dendritic cell interactions: consequences for coronary artery disease. J. Oral Microbiol. 2, doi:10.3402/jom.v2i0.5782 (2010).
53. Pollreisz A, Huang Y, Roth GA et al. Enhanced monocyte migration and proinfammatory cytokine production by Porphyromonas gingivalis infection. J. Periodontal Res. 45(2), 239-245 (2010).
54. Chavakis T, Wiechmann K, Preissner KT, Herrmann M. Staphylococcus aureus interactions with the endothelium: the role of bacterial 'secretable expanded repertoire adhesive molecules' (SERAM) in disturbing host defense systems. Thromb. Haemost. 94(2), 278-285 (2005). (Pubitemid 41122481)
55. Nobbs AH, Lamont RJ, Jenkinson HF. Streptococcus adherence and colonization. Microbiol. Mol. Biol. Rev. 73(3), 407-450, Table of Contents (2009).
56. Amano A. Bacterial adhesins to host components in periodontitis. Periodontol. 2000 52(1), 12-37 (2010).
57. Tribble GD, Lamont RJ. Bacterial invasion of epithelial cells and spreading in periodontal tissue. Periodontol. 2000 52(1), 68-83 (2010).
58. Deshpande RG, Khan MB, Genco CA. Invasion of aortic and heart endothelial cells by Porphyromonas gingivalis. Infect. Immun. 66(11), 5337-5343 (1998). (Pubitemid 29044628)
59. Dorn BR, Dunn WA Jr, Progulske-Fox A. Invasion of human coronary artery cells by periodontal pathogens. Infect. Immun. 67(11), 5792-5798 (1999). (Pubitemid 29508100)
60. Dorn BR, Dunn WA Jr, Progulske-Fox A. Porphyromonas gingivalis traffcs to autophagosomes in human coronary artery endothelial cells. Infect. Immun. 69(9), 5698-5708 (2001). (Pubitemid 32786508)
61. Roth GA, Ankersmit HJ, Brown VB, Papapanou PN, Schmidt AM, Lalla E. Porphyromonas gingivalis infection and cell death in human aortic endothelial cells. FEMS Microbiol. Lett. 272(1), 106-113 (2007). (Pubitemid 46944455)
62. Li L, Michel R, Cohen J, DeCarlo A, Kozarov E. Intracellular survival and vascular cell-to-cell transmission of Porphyromonas gingivalis. BMC Microbiol. 8, 26-36 (2008).
63. Abranches J, Zeng L, Belanger M et al. Invasion of human coronary artery endothelial cells by Streptococcus mutans OMZ175. Oral Microbiol. Immunol. 24(2), 141-145 (2009).
64. Nakano K, Inaba H, Nomura R et al. Detection of cariogenic Streptococcus mutans in extirpated heart valve and atheromatous plaque specimens. J. Clin. Microbiol. 44(9), 3313-3317 (2006). (Pubitemid 44413770)
65. + E. coli K1 invasion of human brain microvascular endothelial cells. Biochem. J. 427(1), 79-90 (2010).
66. Rodrigues PH, Belanger M, Dunn W Jr, Progulske-Fox A. Porphyromonas gingivalis and the autophagic pathway: an innate immune interaction? Front. Biosci. 13, 178-187 (2008). (Pubitemid 351594769)
67. Huang J, Brumell JH. Autophagy in immunity against intracellular bacteria. Curr. Top Microbiol. Immunol. 335, 189-215 (2009).
68. Jo EK. Innate immunity to mycobacteria: vitamin D and autophagy. Cell. Microbiol. 12(8), 1026-1035 (2010).
69. Vazquez CL, Colombo MI. Beclin 1 modulates the antiapoptotic activity of Bcl-2: insights from a pathogen infection system. Autophagy 6(1), 177-178 (2010).
70. Levine B, Deretic V. Unveiling the roles of autophagy in innate and adaptive immunity. Nat. Rev. Immunol. 7(10), 767-777 (2007). (Pubitemid 47480305)
71. Yilmaz O, Verbeke P, Lamont RJ, Ojcius DM. Intercellular spreading of Porphyromonas gingivalis infection in primary gingival epithelial cells. Infect. Immun. 74(1), 703-710 (2006). (Pubitemid 43023126)
72. Stassen FR, Vainas T, Bruggeman CA. Infection and atherosclerosis. An alternative view on an outdated hypothesis. Pharmacol. Rep. 60(1), 85-92 (2008). (Pubitemid 351586546)
73. Niu J, Kolattukudy PE. Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications. Clin. Sci. (London) 117(3), 95-109 (2009).
74. Hajishengallis G, Tapping RI, Harokopakis E et al. Differential interactions of fmbriae and lipopolysaccharide from Porphyromonas gingivalis with the Toll-like receptor 2-centred pattern recognition apparatus. Cell. Microbiol. 8(10), 1557-1570 (2006). (Pubitemid 44350015)
75. Khlgatian M, Nassar H, Chou HH, Gibson FC 3rd, Genco CA. Fimbria-dependent activation of cell adhesion molecule expression in Porphyromonas gingivalis-infected endothelial cells. Infect. Immun. 70(1), 257-267 (2002). (Pubitemid 34028626)
76. Takahashi Y, Davey M, Yumoto H, Gibson FC 3rd, Genco CA. Fimbria-dependent activation of proinfammatory molecules in Porphyromonas gingivalis infected human aortic endothelial cells. Cell. Microbiol. 8(5), 738-757 (2006).
77. Chou HH, Yumoto H, Davey M et al. Porphyromonas gingivalis fmbria-dependent activation of infammatory genes in human aortic endothelial cells. Infect. Immun. 73(9), 5367-5378 (2005). (Pubitemid 41192970)
78. Martinet W, Schrijvers DM, De Meyer GR. Necrotic cell death in atherosclerosis. Basic Res. Cardiol. (2011).
79. Kozarov E, Li L, Michel R, Rodriguez R, DeCarlo AA. Differential activity of P. gingivalis-secreted proteins toward polarized human endothelial cells. J. Dental Res. 82(Special Issue B), B180 (2003).
80. Roth GA, Aumayr K, Giacona MB, Papapanou PN, Schmidt AM, Lalla E. Porphyromonas gingivalis infection and prothrombotic effects in human aortic smooth muscle cells. Thromb. Res. 123(5), 780-784 (2009).
81. Wada K, Kamisaki Y. Roles of oral bacteria in cardiovascular diseases-from molecular mechanisms to clinical cases: involvement of Porphyromonas gingivalis in the development of human aortic aneurysm. J. Pharmacol. Sci. 113(2), 115-119 (2010).
82. Herzberg MC, Nobbs A, Tao L et al. Oral streptococci and cardiovascular disease: searching for the platelet aggregation-associated protein gene and mechanisms of Streptococcus sanguis-induced thrombosis. J. Periodontol. 76(Suppl. 11), 2101-2105 (2005). (Pubitemid 41748959)
83. Brevetti G, Giugliano G, Brevetti L, Hiatt WR. Infammation in peripheral artery disease. Circulation 122(18), 1862-1875 (2010).
84. Sato Y, Kishi J, Suzuki K, Nakamura H, Hayakawa T Sonic extracts from a bacterium related to periapical disease activate gelatinase A and inactivate tissue inhibitor of metalloproteinases TIMP-1 and TIMP-2. Int. Endod. J. 42(12), 1104-1111 (2009).
85. Guan SM, Shu L, Fu SM, Liu B, Xu XL, Wu JZ. Prevotella intermedia upregulates MMP-1 and MMP-8 expression in human periodontal ligament cells. FEMS Microbiol. Lett. 299(2), 214-222 (2009).
86. Graves DT, Fine D, Teng YT, Van Dyke TE, Hajishengallis G. The use of rodent models to investigate host-bacteria interactions related to periodontal diseases. J. Clin. Periodontol. 35(2), 89-105 (2008).
87. Gibson FC 3rd, Hong C, Chou HH et al. Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-defcient mice. Circulation 109(22), 2801-2806 (2004). (Pubitemid 38737928)
88. Amar S, Wu SC, Madan M. Is Porphyromonas gingivalis cell invasion required for atherogenesis? Pharmacotherapeutic implications. J. Immunol. 182(3), 1584-1592 (2009).
89. Dewhirst FE, Chen T, Izard J et al. The human oral microbiome. J. Bacteriol. 192(19), 5002-5017 (2010).
90. Parahitiyawa NB, Scully C, Leung WK, Yam WC, Jin LJ, Samaranayake LP. Exploring the oral bacterial fora: current status and future directions. Oral Dis. 16(2), 136-145 (2010).
91. Beck JD, Offenbacher S. Relationships among clinical measures of periodontal disease and their associations with systemic markers. Ann. Periodontol. 7(1), 79-89 (2002).
92. Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, Genco RJ. Identifcation of periodontal pathogens in atheromatous plaques. J. Periodontol. 71(10), 1554-1560. (2000).
93. Bahrani-Mougeot FK, Paster BJ, Coleman S et al. Molecular analysis of oral and respiratory bacterial species associated with ventilator-associated pneumonia. J. Clin. Microbiol. 45(5), 1588-1593 (2007). (Pubitemid 46762418)
94. Cole JR, Chai B, Farris RJ et al. The ribosomal database project (RDP-II): introducing myRDP space and quality controlled public data. Nucleic Acids Res. 35(Database issue), D169-D172 (2007). (Pubitemid 46056192)
95. Padilla C, Lobos O, Hubert E et al. Periodontal pathogens in atheromatous plaques isolated from patients with chronic periodontitis. J. Periodontal Res. 41(4), 350-353 (2006). (Pubitemid 44392307)
96. Koren O, Spor A, Felin J et al. Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc. Natl Acad. Sci. USA 108(Suppl. 1), 4592-4598 (2011).
97. Ford PJ, Gemmell E, Chan A et al. Infammation, heat shock proteins and periodontal pathogens in atherosclerosis: an immunohistologic study. Oral Microbiol. Immunol. 21(4), 206-211 (2006). (Pubitemid 44336949)
98. Fiehn NE, Larsen T, Christiansen N, Holmstrup P, Schroeder T V. Identifcation of periodontal pathogens in atherosclerotic vessels. J. Periodontol. 76(5), 731-736 (2005). (Pubitemid 40852385)
99. Kozarov E, Dorn B, Shelburne C, Dunn W, Progulske-Fox A. Human atherosclerotic plaque contains viable invasive Porphyromonas gingivalis and Actinobacillus actinomycetemcomitans. Arterioscler. Thromb. Vasc. Biol. 25(3), e17-e18 (2005).
100. Kusner DJ. Mechanisms of mycobacterial persistence in tuberculosis. Clin. Immunol. 114(3), 239-247 (2005). (Pubitemid 40255129)
101. Steinert M, Emody L, Amann R, Hacker J. Resuscitation of viable but nonculturable Legionella pneumophila Philadelphia JR32 by Acanthamoeba castellanii. Appl. Environ. Microbiol. 63(5), 2047-2053 (1997). (Pubitemid 27194873)
102. Schoedon G, Goldenberger D, Forrer R et al. Deactivation of macrophages with interleukin-4 is the key to the isolation of Tropheryma whippelii. J. Infect. Dis. 176(3), 672-677 (1997). (Pubitemid 27360532)
103. Rafferty B, Jönsson D, Kalachikov S et al. Impact of monocytic cells on recovery of uncultivable bacteria from atherosclerotic lesions. J. Intern. Med. 270(3), 273-280 (2011).
104. Fujii R, Saito Y, Tokura Y, Nakagawa KI, Okuda K, Ishihara K. Characterization of bacterial fora in persistent apical periodontitis lesions. Oral Microbiol. Immunol. 24(6), 502-505 (2009).
105. Debelian GJ, Olsen I, Tronstad L. Anaerobic bacteremia and fungemia in patients undergoing endodontic therapy: an overview. Ann. Periodontol. 3(1), 281-287 (1998).
106. Caplan DJ, Pankow JS, Cai J, Offenbacher S, Beck JD. The relationship between self-reported history of endodontic therapy and coronary heart disease in the Atherosclerosis Risk in Communities Study. J. Am. Dent. Assoc. 140(8), 1004-1012 (2009).
107. Nataloni M, Pergolini M, Rescigno G, Mocchegiani R. Prosthetic valve endocarditis. J. Cardiovasc. Med. (Hagerstown) 11(12), 869-883 (2010).
108. Rafferty B, Dolgilevich S, Kalachikov S et al. Cultivation of Enterobacter hormaechei from human atherosclerotic tissue. J. Atheroscler. Thromb. 18(1), 72-81 (2011).
109. D'Aiuto F, Parkar M, Nibali L, Suvan J, Lessem J, Tonetti MS. Periodontal infections cause changes in traditional and novel cardiovascular risk factors: results from a randomized controlled clinical trial. Am. Heart J. 151(5), 977-984 (2006).
110. Tonetti MS, D'Aiuto F, Nibali L et al. Treatment of periodontitis and endothelial function. N. Engl. J. Med. 356(9), 911-920 (2007). (Pubitemid 46339910)
111. Seinost G, Wimmer G, Skerget M et al. Periodontal treatment improves endothelial dysfunction in patients with severe periodontitis. Am. Heart J. 149(6), 1050-1054 (2005). (Pubitemid 40848150)
112. Papapanou PN, Sedaghatfar MH, Demmer RT et al. Periodontal therapy alters gene expression of peripheral blood monocytes. J. Clin. Periodontol. 34(9), 736-747 (2007).
113. Lalla E, Kaplan S, Yang J, Roth GA, Papapanou PN, Greenberg S. Effects of periodontal therapy on serum C-reactive proteins, E-selectin, and tumor necrosis factor-alpha secretion by peripheral blood-derived macrophages in diabetes. A pilot study. J. Periodontal Res. 42(3), 274-282 (2007).
114. Piconi S, Trabattoni D, Luraghi C et al. Treatment of periodontal disease results in improvements in endothelial dysfunction and reduction of the carotid intima-media thickness. FASEB J. 23(4), 1196-1204 (2009).
115. Paju S, Pussinen PJ, Sinisalo J et al. Clarithromycin reduces recurrent cardiovascular events in subjects without periodontitis. Atherosclerosis 188(2), 412-419 (2006). (Pubitemid 44301140)
116. Paju S, Sinisalo J, Pussinen PJ, Valtonen V, Nieminen MS. Is periodontal infection behind the failure of antibiotics to prevent coronary events? Atherosclerosis 193(1), 193-195 (2007). (Pubitemid 46776699)
117. Scannapieco FA, Dasanayake A P, Chhun N. Does periodontal therapy reduce the risk for systemic diseases? Dent. Clin. North Am. 54(1), 163-181 (2010).
118. Rimbara E, Fischbach LA, Graham DY. Optimal therapy for Helicobacter pylori infections. Nat. Rev. Gastroenterol. Hepatol. 8(2), 79-88 (2011).
119. Marshall BJ, Warren JR. Unidentifed curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1(8390), 1311-1315 (1984).
120. Eskelinen EL, Saftig P. Autophagy: a lysosomal degradation pathway with a central role in health and disease. Biochim. Biophys. Acta 1793(4), 664-673 (2009).
121. Lerena MC, Vazquez CL, Colombo MI. Bacterial pathogens and the autophagic response. Cell. Microbiol. 12(1), 10-18 (2010).
122. Travassos LH, Carneiro LA, Ramjeet M et al. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat. Immunol. 11(1), 55-62 (2010).
123. Liu PT, Stenger S, Li H et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311(5768), 1770-1773 (2006).
124. Yuk JM, Shin DM, Lee HM et al. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe 6(3), 231-243 (2009).
125. Foster LJ, Chan QW. Lipid raft proteomics: more than just detergent-resistant membranes. Subcell. Biochem. 43, 35-47 (2007).
126. Seveau S, Pizarro-Cerda J, Cossart P. Molecular mechanisms exploited by Listeria monocytogenes during host cell invasion. Microbes Infect. 9(10), 1167-1175 (2007). (Pubitemid 47375144)
127. Zaas DW, Duncan M, Rae Wright J, Abraham SN. The role of lipid rafts in the pathogenesis of bacterial infections. Biochim. Biophys. Acta 1746(3), 305-313 (2005). (Pubitemid 41815024)
128. Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature 473(7347), 317-325 (2011).
129. Tufariello JM, Chan J, Flynn JL. Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection. Lancet Infect. Dis. 3(9), 578-590 (2003). (Pubitemid 37064537)
130. Domingue GJ Sr, Woody HB. Bacterial persistence and expression of disease. Clin. Microbiol. Rev. 10(2), 320-344 (1997). (Pubitemid 27196674)
131. Garduno RA, Garduno E, Hiltz M, Hoffman PS. Intracellular growth of Legionella pneumophila gives rise to a differentiated form dissimilar to stationary-phase forms. Infect. Immun. 70(11), 6273-6283 (2002). (Pubitemid 35192719)
132. Lin MY, Ottenhoff TH. Host-pathogen interactions in latent Mycobacterium tuberculosis infection: identifcation of new targets for tuberculosis intervention. Endocr. Metab. Immune Disord. Drug Targets 8(1), 15-29 (2008).
133. Lin MY, Geluk A, Smith SG et al. Lack of immune responses to Mycobacterium tuberculosis DosR regulon proteins following Mycobacterium bovis BCG vaccination. Infect. Immun. 75(7), 3523-3530 (2007). (Pubitemid 47040954)